The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2017 at "Complementary therapies in medicine"
DOI: 10.1016/j.ctim.2017.08.007
Abstract: BACKGROUND & AIMS Blood transfusion therapy is lifesaving for individuals with β-thalassemia major (β-TM). Iron burden following blood transfusion is the main cause of oxidative stress (OS) and organ dysfunction in these patients. The aim… read more here.
Keywords: oxidative status; silymarin; thalassemia major; antioxidant oxidative ... See more keywords